Literature DB >> 12739734

Acromegaly: are new tests needed?

Anna Spada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12739734     DOI： 10.1007/BF03345135

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  12 in total

Review 1.  Criteria for cure of acromegaly: a consensus statement.

Authors:  A Giustina; A Barkan; F F Casanueva; F Cavagnini; L Frohman; K Ho; J Veldhuis; J Wass; K Von Werder; S Melmed
Journal:  J Clin Endocrinol Metab       Date:  2000-02       Impact factor: 5.958

Review 2.  Editorial: acromegaly--consensus, what consensus?

Authors:  Peter J Trainer
Journal:  J Clin Endocrinol Metab       Date:  2002-08       Impact factor: 5.958

Review 3.  Guidelines for acromegaly management.

Authors:  S Melmed; F F Casanueva; F Cavagnini; P Chanson; L Frohman; A Grossman; K Ho; D Kleinberg; S Lamberts; E Laws; G Lombardi; M L Vance; K Von Werder; J Wass; A Giustina
Journal:  J Clin Endocrinol Metab       Date:  2002-09       Impact factor: 5.958

Review 4.  Acromegaly: what constitutes optimal therapy?

Authors:  L A Frohman
Journal:  J Clin Endocrinol Metab       Date:  1996-02       Impact factor: 5.958

Review 5.  Acromegaly.

Authors:  S Melmed
Journal:  N Engl J Med       Date:  1990-04-05       Impact factor: 91.245

6.  The importance of insulin-like growth factor (somatomedin) measurements in the diagnosis and surveillance of acromegaly.

Authors:  M Rieu; F Girard; H Bricaire; M Binoux
Journal:  J Clin Endocrinol Metab       Date:  1982-07       Impact factor: 5.958

7.  Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up.

Authors:  Eleni V Dimaraki; Craig A Jaffe; Roberta DeMott-Friberg; William F Chandler; Ariel L Barkan
Journal:  J Clin Endocrinol Metab       Date:  2002-08       Impact factor: 5.958

8.  Determinants of clinical outcome and survival in acromegaly.

Authors:  C Rajasoorya; I M Holdaway; P Wrightson; D J Scott; H K Ibbertson
Journal:  Clin Endocrinol (Oxf)       Date:  1994-07       Impact factor: 3.478

9.  Growth hormone pulsatility in active and cured acromegalic subjects.

Authors:  M Semer; A C Faria; M Nery; L R Salgado; M Knoepfelmacher; B L Wajchenberg; B Liberman
Journal:  J Clin Endocrinol Metab       Date:  1995-12       Impact factor: 5.958

10.  Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.

Authors:  P U Freda; K D Post; J S Powell; S L Wardlaw
Journal:  J Clin Endocrinol Metab       Date:  1998-11       Impact factor: 5.958
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.